Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Invatec gains access to US market with ev3 deal:

This article was originally published in Clinica

Executive Summary

Italian company Invatec has appointed Plymouth, Minnesota-based ev3 as exclusive distributor of its endovascular products in the US. The deal represents Brescia-based company's entry into this significant market for the first time. Invatec will also team up with ev3 to commercialise Invatec's new technology aimed at the embolic protection and thrombectomy markets. ev3, a young, privately-held company involved in developing endovascular technologies, will see its product line expand with this new alliance, particularly in the areas of peripheral angioplasty balloon catheters, balloon-expandable and self-expanding stent systems and guidewires.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059033

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel